IBEX Technologies Inc.

IBEX Technologies Inc.

July 13, 2017 08:44 ET

IBEX Reports Change in Board Composition

MONTREAL, QUEBEC--(Marketwired - July 13, 2017) - IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE:IBT) today reported the death of Bernard Patriacca, a long-serving board member and Chairman of its Audit Committee.

"We are extremely saddened by the news of Mr. Patriacca's passing" said Paul Baehr, IBEX Chairman and CEO. "Bernie was a very experienced, competent and diligent member of our Board and will be missed".

Danilo Netto, currently a member of the IBEX Audit Committee, and also Vice President Finance, Avior Integrated Products Inc., will assume Mr. Patriacca's role as Chairman of the Audit Committee.

The IBEX Governance Committee, chaired by Robert DeLuccia, will commence a search to fill the vacancy on the IBEX Board.


IBEX manufactures and markets proteins for biomedical use through its wholly owned subsidiaries IBEX Pharmaceuticals Inc. (Montreal, QC) and Bio-Research Products, Inc. (North Liberty, IA). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays which are widely used in osteoarthritis research.

For more information, please visit the Company's website at www.ibex.ca.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Paul Baehr
    President & CEO
    IBEX Technologies Inc.
    514-344-4004 x 143